Inventor · disambiguated record
Leonard Bell
Also filed as: BELL LEONARD · BELL LEONARD E
17 granted patents·20 pending applications·318 citations·filing 1980–2020
95Inventor score
Top patents by PatentIndex Score
37 records- 0196US9718880B2Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complementALEXION PHARMA INC·Filed 2016·Granted Aug 1, 2017·17 cites·3 claims
- 0295US10703809B1Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complementALEXION PHARMA INC·Filed 2020·Granted Jul 7, 2020·3 cites·29 claims
- 0395US9732149B2Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complementALEXION PHARMA INC·Filed 2016·Granted Aug 15, 2017·15 cites·1 claims
- 0495US9725504B2Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complementALEXION PHARMA INC·Filed 2016·Granted Aug 8, 2017·14 cites·10 claims
- 0594US9447176B2Methods and compositions for treating complement-associated disordersROTHER RUSSELL P·Filed 2009·Granted Sep 20, 2016·21 cites·4 claims
- 0693US9771418B2Methods for treating complement-associated disordersALEXION PHARMA INC·Filed 2016·Granted Sep 26, 2017·8 cites·4 claims
- 0792US10590189B2Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complementALEXION PHARMA INC·Filed 2017·Granted Mar 17, 2020·7 cites·8 claims
- 0890US7757493B2Fluid catalytic cracking steam pressure letdown power recovery system and processUOP LLC·Filed 2006·Granted Jul 20, 2010·20 cites·18 claims
- 0989US7048782B1Apparatus and process for power recoveryUOP LLC·Filed 2003·Granted May 23, 2006·48 cites·19 claims
- 1086US7361339B2Methods for reducing morality associated with acute myocardial infarctionALEXION PHARMA INC·Filed 2003·Granted Apr 22, 2008·25 cites·23 claims
- 1181US6916654B1Universal donor cellsUNIV YALE·Filed 2000·Granted Jul 12, 2005·22 cites·13 claims
- 1278US6100443AUniversal donor cellsOKLAHOMA MED RES FOUND·Filed 1995·Granted Aug 8, 2000·31 cites·17 claims
- 1372US2020392216A1Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complementALEXION PHARMA INC·Filed 2020·Application pending·0 cites
- 1470US5705732AUniversal donor cellsOKLAHOMA MED RES FOUND·Filed 1993·Granted Jan 6, 1998·24 cites·5 claims
- 1570US2020140531A1Methods for treating complement-associated disordersALEXION PHARMA INC·Filed 2019·Application pending·0 cites
- 1669US2010068202A1Method of treating hemolytic diseaseALEXION PHARMA INC·Filed 2009·Application pending·0 cites
- 1768US4338344AProcess for producing a quick-cooking riceGEN FOODS CORP·Filed 1980·Granted Jul 6, 1982·25 cites·24 claims
- 1865US2017369562A1Methods for treating complement-associated disordersALEXION PHARMA INC·Filed 2017·Application pending·0 cites
- 1963US2009220508A1Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementALEXION PHARMA INC·Filed 2007·Application pending·0 cites
- 2062US2017015740A1Methods for treating complement-associated disordersALEXION PHARMA INC·Filed 2016·Application pending·0 cites
- 2161US2012237515A1Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complementBELL LEONARD·Filed 2012·Application pending·0 cites
- 2261US2016319004A1Methods and compositions for treating complement-associated disordersALEXION PHARMA INC·Filed 2016·Application pending·0 cites
- 2359US2004081619A1Method of prophylaxis against large myocardial infarctionsFiled 2003·Application pending·0 cites
- 2458US2005169921A1Method of treating hemolytic diseaseFiled 2004·Application pending·0 cites
- 2558US2012308559A1Method of treating hemolytic diseaseBELL LEONARD·Filed 2011·Application pending·0 cites
- 2657US2005191298A1Method of treating hemolytic diseaseFiled 2005·Application pending·0 cites
- 2756US11244744B2Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitorALEXION PHARMA INC·Filed 2017·Granted Feb 8, 2022·0 cites·11 claims
- 2855US2011086040A1Method of treating hemolytic diseaseALEXION PHARMA INC·Filed 2010·Application pending·0 cites
- 2954US2002094332A1Method of prophylaxis against large myocardial infractionsALEXION PHARMACEUTICALS·Filed 2002·Application pending·0 cites
- 3053US11031102B2Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitorALEXION PHARMA INC·Filed 2015·Granted Jun 8, 2021·0 cites·7 claims
- 3153US2013246083A1Methods of distributing complement-inhibiting drugs to patients receiving a complement inhibitorBELL LEONARD·Filed 2012·Application pending·0 cites
- 3250US5336615AGenetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activityUNIV YALE·Filed 1992·Granted Aug 9, 1994·38 cites·19 claims
- 3349US2010243528A1Method and system relating to a wet gas compressorBELL LEONARD E·Filed 2009·Application pending·0 cites
- 3446US2007116710A1Methods of treating hemolytic anemiaBELL LEONARD·Filed 2006·Application pending·0 cites
- 3544US2006266048A1Fluid catalytic cracking flue gas utility optimizing system and processBELL LEONARD E·Filed 2005·Application pending·0 cites
- 3642US2003049260A1Method of improving cognitive functionFiled 2002·Application pending·0 cites
- 3737US2018142010A1Method for treating a patient in compliance with vaccination with eculizumab or an eculizumab variantALEXION PHARMA INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Leonard Bell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →